Healthcare & Life Sciences
DiCE Molecules
United Stateswww.dicemolecules.com/
DiCE Molecules is a series c plus startup based in United States. 1 investor tracked. Status: acquired.
Acquiredseries-c-plus
series-c-plus
Stage
2016
Founded
2
Investors
About DiCE Molecules
Based in the United States, DiCE Molecules is a startup founded in 2016. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
DiCE Molecules is a biopharmaceutical company leveraging its proprietary DNA-encoded library (DEL) platform to discover and develop novel oral therapeutic candidates for immunology and other diseases.
Explore DiCE Molecules's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.